81633-75-2

Upstream product

• 506-68-3 bromocyane 
• 56030-50-3 (+)-(R)-1-phenyl-N-methyl-7,8-dimethoxy-1,2,4,5-tetrahydro-3H-benzazepine 
• 62717-89-9 (-)-(S)-1-phenyl-N-methyl-7,8-dimethoxy-1,2,4,5-tetrahydro-3H-benzazepine 
• 20012-08-2 1-phenyl-N-methyl-7,8-dimethoxy-1,2,4,5-tetrahydro-3H-benzazepine 

Downstream Products

• 62717-90-2 (1R)-(+)-7,8-dimethoxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine 
• 62717-13-9 (R)-3-benzyl-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine 
• 62717-92-4 (R)-3-benzyl-2,3,4,5-tetrahydro-7,8-dimethoxy-1-phenyl-1H-3-benzazepine 
• 42738-59-0 (1S)-(-)-7,8-dimethoxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine 
• 62717-91-3 (S)-3-benzyl-2,3,4,5-tetrahydro-7,8-dimethoxy-1-phenyl-1H-3-benzazepine 

Relevant academic research and scientific papers

Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine

Resolution of the unique dopamine receptor agonist 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine (1) was achieved by a stereospecific multistep conversion of the readily separated enantiomers of its O,O,N-trimethylated diffractometric analysi